Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Managing-Director"

1478 News Found

We expect to turn profitable in two years: M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed
interviews | February 09, 2022

We expect to turn profitable in two years: M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed

MedleyMed is present across the pharma and healthcare value chain. It offers digital solutions to all stake holders and is in the process of expanding its operations in India and USA. In an interview with Thomas C Thottathil, M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed discussed his plans and opportunities in India

Ascent Meditech chalks out ambitious growth plans: Rajiv Mistry, Founder & Managing Director, Ascent Group
interviews | February 03, 2022

Ascent Meditech chalks out ambitious growth plans: Rajiv Mistry, Founder & Managing Director, Ascent Group

Ascent Meditech has set benchmarks in introducing pain management products in India. The company has embarked on a new marketing campaign as it plans to enter new markets. Rajiv Mistry, Founder & Managing Director, Ascent Group shares his perspective with Thomas C Thottathil on the road ahead for the company and industry

Govt approval to KIHT as CRO expands India’s innovation capabilities
Clinical Trials | June 12, 2026

Govt approval to KIHT as CRO expands India’s innovation capabilities

KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation

Narayana Health achieves HIMSS AMAM Stage 6, first in Indian subcontinent
Hospitals | June 12, 2026

Narayana Health achieves HIMSS AMAM Stage 6, first in Indian subcontinent

Recognition highlights the hospital network’s decade-long investment in analytics and AI-driven healthcare, supporting improved outcomes, efficiency, and affordability.

Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases
News | June 12, 2026

Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases

The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients

Symeres expands spray drying capabilities to accelerate small-molecule drug development in New Jersey
News | June 11, 2026

Symeres expands spray drying capabilities to accelerate small-molecule drug development in New Jersey

Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials

ASMS explores strategic research collaboration with Mediciti Institute
News | June 11, 2026

ASMS explores strategic research collaboration with Mediciti Institute

Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings

AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab
Drug Approval | June 11, 2026

AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab

Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer

Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore
News | June 10, 2026

Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore

The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe

Oval Fertility and Merck India partner to advance access to high-quality fertility care
Healthcare | June 10, 2026

Oval Fertility and Merck India partner to advance access to high-quality fertility care

Strategic collaboration aims to strengthen clinical capabilities, enhance patient experience and improve fertility treatment outcomes through scientific expertise, technology and data-driven care

Upcoming E-conference
June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM

Biopharma SHAKTI envisages launch of 100 biologics by 2047: Anupriya Patel

Major UK study to evaluate newborn screening for spinal muscular atrophy

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation
From bench to work flow, we are an integrated solution provider: K.O. Satish, Associate Vice President, Spinco Biotech
From bench to work flow, we are an integrated solution provider: K.O. Satish, Associate Vice President, Spinco Biotech
Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences
Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences
Dr. Ramesh Hariharan Chief Executive Officer, Strand Life Sciences

Packaging